EP 2405914 A1 20120118 - COMPOSITIONS AND METHODS FOR PROPHYLAXIS AND TREATMENT OF ADDICTIONS
Title (en)
COMPOSITIONS AND METHODS FOR PROPHYLAXIS AND TREATMENT OF ADDICTIONS
Title (de)
ZUSAMMENSETZUNGEN UND VERFAHREN ZUR PROPHYLAXE UND BEHANDLUNG VON SUCHTZUSTÄNDEN
Title (fr)
COMPOSITIONS ET MÉTHODES POUR LA PROPHYLAXIE ET LE TRAITEMENT D'ADDICTIONS
Publication
Application
Priority
- US 2010027048 W 20100311
- US 15937709 P 20090311
- US 16782409 P 20090408
Abstract (en)
[origin: WO2010105103A1] The present invention relates to methods of treating or preventing addiction and relapse use of addictive agents, and treating or preventing addictive or compulsive behaviour and relapse practice of an addictive behaviour or compulsion, by administering a peroxisome proliferator-activated receptor gamma (PPAR ) agonist, alone or in combination with another therapeutic agent, such as, for example, an opioid receptor antagonist or an antidepressant, or an addictive agent, such as, for example, an opioid agonist. The present invention also includes pharmaceutical compositions for treating or preventing addiction or relapse that include a PPAR agonist and one or more other therapeutic or addictive agents, as well as unit dosage forms of such pharmaceutical compositions, which contain a dosage effective in treating or preventing addiction or relapse. The methods and compositions of the invention are useful in the treatment or prevention of addiction to any agent, including alcohol, nicotine, marijuana, cocaine, and amphetamines, as well as compulsive and addictive behaviours, including pathological gambling and pathological overeating.
IPC 8 full level
A61K 31/4439 (2006.01); A61K 31/138 (2006.01); A61K 31/195 (2006.01); A61K 31/35 (2006.01); A61K 31/4015 (2006.01); A61K 31/4178 (2006.01); A61K 31/445 (2006.01); A61K 31/485 (2006.01); A61K 31/519 (2006.01); A61P 25/32 (2006.01); A61P 25/34 (2006.01); A61P 25/36 (2006.01)
CPC (source: EP KR)
A61K 31/137 (2013.01 - EP KR); A61K 31/138 (2013.01 - EP KR); A61K 31/195 (2013.01 - EP KR); A61K 31/35 (2013.01 - EP KR); A61K 31/4015 (2013.01 - EP KR); A61K 31/4178 (2013.01 - EP KR); A61K 31/4439 (2013.01 - EP KR); A61K 31/445 (2013.01 - EP KR); A61K 31/485 (2013.01 - EP KR); A61K 31/519 (2013.01 - EP KR); A61K 45/06 (2013.01 - EP KR); A61P 25/04 (2017.12 - EP); A61P 25/30 (2017.12 - EP); A61P 25/32 (2017.12 - EP); A61P 25/34 (2017.12 - EP); A61P 25/36 (2017.12 - EP); A61P 43/00 (2017.12 - EP)
C-Set (source: EP)
Citation (search report)
See references of WO 2010105103A1
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR
DOCDB simple family (publication)
WO 2010105103 A1 20100916; AU 2010224037 A1 20111027; AU 2010224037 B2 20150205; BR PI1009141 A2 20160308; CA 2754901 A1 20100916; CN 102348457 A 20120208; CN 106692144 A 20170524; EP 2405914 A1 20120118; EP 3398599 A1 20181107; JP 2012520320 A 20120906; JP 6163289 B2 20170712; KR 101767273 B1 20170810; KR 20110127263 A 20111124; KR 20170093264 A 20170814; MX 2011009384 A 20111011; NZ 595545 A 20140228; NZ 619408 A 20150828
DOCDB simple family (application)
US 2010027048 W 20100311; AU 2010224037 A 20100311; BR PI1009141 A 20100311; CA 2754901 A 20100311; CN 201080011496 A 20100311; CN 201710016027 A 20100311; EP 10708873 A 20100311; EP 18178072 A 20100311; JP 2011554216 A 20100311; KR 20117023820 A 20100311; KR 20177021817 A 20100311; MX 2011009384 A 20100311; NZ 59554510 A 20100311; NZ 61940810 A 20100311